Drug Trial Radar · NCT06378684
To Evaluate the Safety and Pharmacokinetic Interactions in Healthy Volunteers
Last checked: Nov 19, 2026Latest source record: Apr 22, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
48
Actual
Start
Sep 10, 2023
Primary completion
Dec 23, 2023
Study completion Jan 13, 2024
Sponsor
- Lead sponsor
- JW PharmaceuticalIndustry
- Sponsor type
- Industry
- First posted
- Apr 22, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Other
- FDA-regulated drug
- No
- Who can join
- All sexes, from 19 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The objective is to evaluate the safety and Pharmacokinetic Interactions after adminitration drug(Treatment A or B or A+B) in Healthy Volunteers
Conditions
- Healthy
Interventions
Group 1: JW0104(Period 1), C2207(Period 2), JW0104 + C2207(Period 3)Drug
Tablet, Oral, QD for 10 Days, Washout period is more than 14 days after administration
Group 2: JW0104 + C2207(Period 1), JW0104(Period 2), C2207(Period 3)Drug
Tablet, Oral, QD for 10 Days, Washout period is more than 14 days after administration
Group 3: C2207(Period 1), JW0104 + C2207(Period 2), JW0104(Period 3)Drug
Tablet, Oral, QD for 10 Days, Washout period is more than 14 days after administration
Group 4: JW0104(Period 1), JW0104 + C2207(Period 2), C2207(Period 3)Drug
Tablet, Oral, QD for 10 Days, Washout period is more than 14 days after administration
Group 5: JW0104 + C2207(Period 1), C2207(Period 2), JW0104(Period 3)Drug
Tablet, Oral, QD for 10 Days, Washout period is more than 14 days after administration
Group 6: C2207(Period 1), JW0104(Period 2), JW0104 + C2207(Period 3)Drug
Tablet, Oral, QD for 10 Days, Washout period is more than 14 days after administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cmax,ssTime frame: Day 1(0 hour), Day 8(0 hour), Day 9(0 hour), Day 10(0 hour) ~ Day 13(72 hours)
- AUCτ,ssTime frame: Day 1(0 hour), Day 8(0 hour), Day 9(0 hour), Day 10(0 hour) ~ Day 13(72 hours)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Clinical Trial Center, Severance Hospital
Seoul, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.